Physician profile
Sandeep Singh
NPI 1073555116
$5,254.80
in general payments reported to CMS, 2019-2025
8 companies · $2,216 in 2025
The $2,216 reported for 2025 was more than what 81% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $739 · 2020: $30.33 · 2021: $114 · 2022: $1,560 · 2023: $595 · 2025: $2,216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,760 · Food and Beverage: $1,051.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,759.97 |
| Food and Beverage | $1,051.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,655.95 | 2019-2025 | Axios, Overstitch Endoscopic Suturing System, Orise |
| Erbe USA INC | $437.37 | 2025 | Erbevio3 |
| Janssen Biotech, INC. | $41.75 | 2023 | |
| Endogastric Solutions, INC | $36.43 | 2023 | Esophyx |
| E.R. Squibb & Sons, L.L.C. | $30.33 | 2020 | |
| Genentech USA, INC. | $19.57 | 2023 | Polivy |
| Ipsen Biopharmaceuticals, INC | $17.77 | 2019 | |
| Apollo Endosurgery US INC | $15.63 | 2023 | X-Tack Endoscopic Helix Tacking System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandeep Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.